Dr. Suriya A. Jeyapalan, MD

Dr. Jeyapalan practices at Tufts Medical Center in Boston, Massachusetts, part of Tufts Medicine.

Dr. Jeyapalan's NPI, 1710934450, was assigned on May 28, 2006. Dr. Jeyapalan graduated from University of Iowa, RJ & L Carver College of Medicine in 1995. Dr. Jeyapalan holds Massachusetts license 159988.

Dr. Jeyapalan's primary practice is Tufts Medical Center, at 800 Washington Street, Boston, MA 02111 in Suffolk County. The practice phone is (617) 636-5000.

Dr. Jeyapalan's primary practice is Tufts Medical Center in Boston, Massachusetts, part of Tufts Medicine. Dr. Jeyapalan is also affiliated with Beth Israel Deaconess Medical Center. The medical group on file is Baystate Medical Practices. Dmand AI also links Dr. Jeyapalan to 2 more hospitals, 3 medical groups and 1 imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jeyapalan practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Jeyapalan's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Jeyapalan is licensed in Massachusetts.

CMS data shows 495 Medicare services from Dr. Jeyapalan across 6 procedure codes in 2024, for 93 Medicare patients. Medicare paid $39,173 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 93 Medicare patients who saw Dr. Jeyapalan in 2024. The largest group is 65 to 74, with 40 patients. 69% of them have high blood pressure, and 59% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jeyapalan's median patient age at 58, with 60% women.

In 2024, Dr. Jeyapalan wrote 462 Medicare Part D claims for 71 patients. 75% of them were for generic drugs. CMS names the drug for 344 of them, across 20 drugs with 11 or more claims each, at $110,349 in total drug cost. In 2023, CMS named 275 claims across 16 drugs.

Dr. Jeyapalan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jeyapalan as offering telehealth.

Dmand AI links 11 papers to Dr. Jeyapalan, published from 2013 to 2022. 2020 was the busiest year, with 2. The most frequent topics are Brain Neoplasms, Antineoplastic Agents, Immunological and Antineoplastic Combined Chemotherapy Protocols. Dr. Jeyapalan has published most often in J Neurooncol. Dr. Jeyapalan's most frequent co-authors are Priya Uday Kumthekar, MD, Morris D. Groves, MD and Fabio Massaiti Iwamoto, MD.

Dmand AI links Dr. Jeyapalan to 6 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Glioblastoma, Brain Neoplasms and Craniopharyngioma. Alliance for Clinical Trials in Oncology sponsors the most, 3.

CMS Open Payments shows 412 general payments to Dr. Jeyapalan from 34 drug and device companies from 2016 to 2025. Compensation for serving as faculty or as a speaker for a medical education program make up the largest share, 37% of the total. Novocure Inc. paid the most, $152,165. It also lists 7 research payments totaling $1,068 in 2016.

Dr. Jeyapalan graduated from University of Iowa, RJ & L Carver College of Medicine in 1995.